母亲体重指数与妊娠结局:系统综述与荟萃分析
该系统综述与荟萃分析纳入13项低偏倚风险的队列研究,共3,722,477例妊娠,评估按世界卫生组织分类的体重指数类别与妊娠结局的关系。结果显示,随着体重指数升高,多数不良妊娠结局风险稳步增加;与体重指数18.5-24.9 kg/m2相比,体重指数>40 kg/m2者的妊娠期糖尿病、妊娠期高血压疾病及剖宫产风险显著升高,婴儿低血糖、巨大儿、感染、产伤、呼吸窘迫、死亡及新生儿重症监护室入院风险亦增加。结论认为母亲体重指数与几乎所有不良妊娠结局呈线性关联。
要点
- 体重指数>40 kg/m2者妊娠期糖尿病风险为4.6倍(95%CI 3.6-5.9)。
- 体重指数>40 kg/m2者妊娠期高血压疾病风险为4.6倍(95%CI 3.4-6.0)。
- 体重指数>40 kg/m2者剖宫产风险为1.86倍(95%CI 1.75-1.97)。
核心结论
- 母亲体重指数与几乎所有不良妊娠结局呈线性关联。
- 按体重指数类别分层的风险数据有助于咨询并促进改善母婴结局的干预。
研究设计与样本
- 因未检索到随机试验,纳入单中心及基于人群的队列研究,按世界卫生组织体重指数分类(偏瘦、标准、超重、肥胖I-III级)分层分析妊娠结局。
- 检索Medline、Embase、PubMed、clinicaltrials.gov及Cochrane五个数据库,自建库至2019年2月,纳入英文或法文文献。
- 最终纳入13项低偏倚风险研究,共描述3,722,477例妊娠。
- 采用纽卡斯尔-渥太华量表评价队列研究质量。
- 因预期存在显著异质性,采用随机效应荟萃分析得出各体重指数类别妊娠结局的合并估计值及95%置信区间,以及相对于标准体重指数女性的相对风险。
主要发现
- 与体重指数18.5-24.9 kg/m2相比,体重指数>40 kg/m2者妊娠期糖尿病发生率为17% vs 3.9%,相对风险4.6(95%CI 3.6-5.9)。
- 体重指数>40 kg/m2者妊娠期高血压疾病发生率为15.9% vs 3.5%,相对风险4.6(95%CI 3.4-6.0)。
- 体重指数>40 kg/m2者剖宫产发生率为47.7% vs 26.0%,相对风险1.86(95%CI 1.75-1.97)。
- 体重指数>40 kg/m2者婴儿低血糖发生率为4.1% vs 1.4%,相对风险3.3(95%CI 2.8-3.8);巨大儿为12.9% vs 6.2%,相对风险2.6(95%CI 1.4-4.7)。
- 体重指数>40 kg/m2者婴儿感染相对风险2.3(95%CI 1.6-3.3),产伤相对风险2.1(95%CI 1.2-3.8),呼吸窘迫相对风险2.0(95%CI 1.8-2.2),死亡相对风险1.8(95%CI 1.2-2.9),新生儿重症监护室入院相对风险1.6(95%CI 1.4-1.9)。
关键数值与推荐
- 体重指数分类依据世界卫生组织国际分类系统:偏瘦、标准体重、超重、肥胖I-III级。
- 与体重指数18.5-24.9 kg/m2相比,体重指数>40 kg/m2者妊娠期糖尿病相对风险4.6(95%CI 3.6-5.9)。
- 体重指数>40 kg/m2者妊娠期高血压疾病相对风险4.6(95%CI 3.4-6.0)。
- 体重指数>40 kg/m2者剖宫产相对风险1.86(95%CI 1.75-1.97)。
- 体重指数>40 kg/m2者婴儿低血糖相对风险3.3(95%CI 2.8-3.8),巨大儿相对风险2.6(95%CI 1.4-4.7),感染相对风险2.3(95%CI 1.6-3.3),产伤相对风险2.1(95%CI 1.2-3.8),呼吸窘迫相对风险2.0(95%CI 1.8-2.2),死亡相对风险1.8(95%CI 1.2-2.9),新生儿重症监护室入院相对风险1.6(95%CI 1.4-1.9)。
临床怎么用
- 可利用按体重指数类别分层的风险数据对孕妇进行咨询,使其了解不良妊娠结局风险随体重指数升高而增加。
- 针对高体重指数孕妇,可鼓励适当干预以改善母婴结局。
局限性
- 未检索到随机试验,仅纳入单中心及基于人群的队列研究。
- 研究间存在显著异质性,故采用随机效应模型进行荟萃分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE DATA: The purpose of this study was to determine the effect of body mass index category on pregnancy outcomes. STUDY: Five databases (Medline, Embase, PubMed, www.clinicaltrials.gov, and Cochrane) were searched from inception until February 2019 for English or French publications that reported on pregnancy outcomes in women with body mass index ≥30 kg/m2. Reference lists of included articles were searched, and authors were contacted for missing data where necessary. Because no randomized trials were identified, we included single-center and population-based cohort studies that stratified pregnancy outcomes under the following body mass index categories: underweight, standard weight, overweight, and obese classes I-III, based on the World Health Organization international classification system. STUDY APPRAISAL AND SYNTHESIS METHODS: Study quality was appraised with the use of the Newcastle-Ottawa Scale Quality Assessment Scale for cohort studies. Because significant heterogeneity was anticipated among studies, we used random-effects metaanalysis to arrive at pooled estimates and 95% confidence intervals for pregnancy outcomes in each body mass index category and relative risks in relation to women with a standard body mass index. RESULTS: We identified 10,258 studies, of which 13 studies with a low risk-of-bias that described 3,722,477 pregnancies that were included in the metaanalysis. Most adverse pregnancy outcomes increased steadily with increasing body mass index category. Compared with women with body mass index 18.5-24.9 kg/m2, women with body mass index >40 kg/m2 were at increased risk for gestational diabetes mellitus [17% vs 3.9%; relative risk, 4.6 [95% confidence interval, 3.6-5.9]), hypertensive disorders of pregnancy (15.9% vs 3.5%; relative risk, 4.6 [95% confidence interval, 3.4-6.0]), and cesarean delivery (47.7% vs 26.0%; relative risk, 1.86 [95% confidence interval, 1.75-1.97]). Babies were at increased risk for hypoglycemia (4.1% vs 1.4%; relative risk, 3.3 [95% confidence interval, 2.8-3.8]), macrosomia (12.9% vs 6.2%; relative risk, 2.6 [95% confidence interval, 1.4-4.7]), infection (2.8% vs 1.3%; relative risk, 2.3 [95% confidence interval, 1.6-3.3]), birth trauma (1.3% vs 0.9%; relative risk, 2.1 [95% confidence interval, 1.2-3.8]), respiratory distress (5.1% vs 2.7%; relative risk, 2.0 [95% confidence interval, 1.8-2.2]), death (1.4% vs 0.9%; relative risk, 1.8 [95% confidence interval, 1.2-2.9]), and neonatal intensive care unit admission (13.5% vs 9.5%; relative risk, 1.6 [95% confidence interval, 1.4-1.9]). CONCLUSION: There is a linear association between maternal body mass index and almost all adverse pregnancy outcomes. These risks, stratified by body mass index category as presented in this article, would facilitate counselling and encourage appropriate interventions to improve outcomes for mothers and babies.
引用
- D'Souza R, Horyn I, Pavalagantharajah S, et al. Maternal body mass index and pregnancy outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol MFM. 2019. PMID: 33345836. doi:10.1016/j.ajogmf.2019.100041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。